When exactly is the legalization of cannabis set to officially take place in Canada? A Senate committee is asking to take an extra year to finetune the actual bill legalizing the drug, but the Canadian leader disagrees.

In that regard, as cannabis investors eagerly await legalization, the Investing News Network (INN) takes a closer look at the current dispute for the implementation of Bill C-45.


Firstly, Bill C-45 faced the recommendation of the Senate’s Aboriginal peoples committee, asking for a delay up to one year for the implementation of the bill in early May.

On the delay and recommendations the CBC wrote:

The committee said the government should take the extra time to make certain “culturally sensitive” materials are available to warn Indigenous peoples about the risks of consuming cannabis, and to negotiate a revenue-sharing deal with First Nations governments to ensure they get a cut of the millions of dollars expected to be collected in excise taxes on the drug.

The senators also recommended the federal government set aside 20 percent of all licenses for cannabis producers for Indigenous peoples so they can pursue business ventures.

The third reading for Bill C-45 is scheduled to take place on June 7. Despite these calls for delays, months away from the expectation of recreational sales, the Canadian government has said it met with Indigenous peoples and considered the issues of these communities.

Speaking to reporters, Prime Minister Justin Trudeau said last week his government is moving forward with the legalization of cannabis this summer despite the suggested delay.

“Obviously, as I’ve said many times, this is not an event, this is a process, and we will continue to work with our partners in the municipalities, in provinces and Indigenous leadership in communities to make sure we’re doing this right and moving forward in a responsible way.”

In February Health Minister Ginette Petitpas Taylor said the federal government will require eight to 12 weeks to fully implement the new legislation across the country.

An analyst’s take on the bill’s process

“There is a growing voice in the Senate to try to torpedo this bill, I don’t know if it has enough legs to do it,” Jason Zandberg, cannabis analyst with PI Financial told INN.

Zandberg expects the bill to pass through third reading and most of the investors he speaks to on an everyday basis expect it as well.

“If I were to give it a percentage I would say 80 or 90 percent chance it is going to pass but that 10 to 20 percent is can change in a hurry,” Zandberg said. His personal prediction for the start of recreational sales is September 1, 2018.

Investor takeaway

While investors of the cannabis space would rather move ahead with a legalized market and take the Senate deliberations as a done deal, any roadblocks to the actual cannabis bill could cause delays on recreational sales and a better review of all cannabis licensed producers (LP) by analysts.

“I always get worried when I talk to an investor and they sort of casually say ‘oh yeah it’s a done deal,’” Zandberg told INN. “Because quite clearly when politics are in play and these are votes that are out of our control I’m always worried.”

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less